HEPATOGLOBINE CAPSULES

Indications

• Vitamin B12 deficiency
• Pernicious anemia
• Neuropathy associated with vitamin B12 deficiency
• Copper deficiency

Dosage

Children: Refer to established guidelines for specific dosing recommendations based on the indication, as dosing may vary depending on clinical circumstances.

Adults: Refer to established guidelines for specific dosing recommendations based on the indication, as dosing may vary depending on clinical circumstances.

Mechanism of action

Cyanocobalamin functions as a coenzyme in the metabolism of certain amino acids and fatty acids, facilitating the conversion of homocysteine to methionine. It is also involved in the synthesis of myelin, which is essential for nerve impulse conduction. Copper is a cofactor for several enzymes, including cytochrome c oxidase, which is involved in mitochondrial respiration, and superoxide dismutase, which protects cells from oxidative damage.

Pharmacodynamics

Cyanocobalamin is absorbed in the ileum and requires intrinsic factor for optimal absorption. Once absorbed, it is stored primarily in the liver, where it can be accessed for various physiological functions. The presence of copper in the formulation enhances the absorption and utilization of iron, contributing to effective erythropoiesis and preventing anemia. Both components support cellular metabolism and overall health.

Pharmacokinetics

Cyanocobalamin is rapidly absorbed when administered parenterally, with peak plasma levels occurring within 1 to 2 hours. Its half-life is approximately 6 days. Copper is absorbed in the gastrointestinal tract, and its bioavailability is influenced by dietary factors. Both cyanocobalamin and copper are excreted primarily via the kidneys.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Folate deficiency
• Pregnancy-related folate supplementation
• Megaloblastic anemia due to folate deficiency
• Neurological disorders requiring folate supplementation

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines.

Adults: Refer to the BNF for specific dosing recommendations based on clinical condition.

Mechanism of action

Fumarate folic acts as a coenzyme in the transfer of one-carbon units in the metabolism of amino acids and nucleic acids. It plays a crucial role in the conversion of homocysteine to methionine, which is an essential process in methylation reactions. This compound is involved in the synthesis of serotonin, dopamine, norepinephrine, and other neurotransmitters, contributing to mood regulation and cognitive function.

Pharmacodynamics

The pharmacodynamic effects of fumarate folic include the enhancement of cellular proliferation and differentiation due to its role in DNA synthesis. It helps maintain normal levels of homocysteine in the blood, which is important for cardiovascular health. Fumarate folic is essential for proper fetal development during pregnancy and is involved in the prevention of neural tube defects.

Pharmacokinetics

Fumarate folic is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1 to 2 hours. It has a bioavailability of approximately 85% when taken in the active form. The elimination half-life varies but is generally around 6 hours. It is metabolized primarily in the liver and excreted in urine. Fumarate folic can cross the blood-brain barrier, thereby exerting effects on the central nervous system.

Contra-indications

• Hypersensitivity to fumarate or any component of the formulation
• Uncontrolled hypertension
• Active or history of thrombosis or thromboembolic disorders

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Rash
• Headache
• Dizziness
• Fatigue

Interactions

• Anticoagulants (increased risk of bleeding)
• Antiepileptics (may reduce the effectiveness of some anticonvulsants)
• Other drugs affecting folate metabolism (such as methotrexate)

Precautions

• Monitor blood pressure regularly
• Assess renal function before and during treatment
• Caution in patients with a history of gastrointestinal disorders
• Use with caution in patients with liver impairment

Pregnancy

Use during pregnancy only if clearly needed. Folic acid is essential for fetal development and may be beneficial.

Breast-feeding

Excreted in breast milk. Use with caution and consult a healthcare provider.

Storage

Store in a tightly closed container at room temperature, away from moisture and light.

Formulations

• Oral tablets
• Oral solution

Indications

• Iron deficiency anemia
• Prevention of iron deficiency in at-risk populations
• Supportive therapy in conditions associated with increased iron demand

Dosage

Children: Refer to specific dosing guidelines for children in a clinical reference or pharmacology text.

Adults: Refer to specific dosing guidelines in a clinical reference or pharmacology text.

Mechanism of action

Peptoneferrous provides ferrous ions (Fe2+) that are readily absorbed in the intestine. The presence of peptones helps in solubilizing iron and enhancing its transport across the intestinal mucosa. Once in the bloodstream, iron is incorporated into hemoglobin, myoglobin, and various enzymes, playing a crucial role in oxygen transportation and cellular metabolism.

Pharmacodynamics

Iron is essential for the synthesis of hemoglobin and other heme-containing proteins. It plays a vital role in oxygen transport and storage, as well as in various enzymatic reactions. The presence of peptones may also modulate the gastrointestinal response, reducing irritation commonly associated with iron supplementation and improving patient tolerance.

Pharmacokinetics

After oral administration, iron from peptoneferrous is absorbed primarily in the duodenum and proximal jejunum. The absorption is influenced by several factors, including the presence of food, pH of the gastrointestinal tract, and the form of iron. Peak plasma concentrations are typically reached within 2 to 6 hours post-ingestion. Iron is then transported bound to transferrin, and excess iron is stored in ferritin and hemosiderin. Renal clearance of iron is minimal, as most excess iron is stored rather than excreted.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Constipation
• Diarrhea
• Allergic reactions

Interactions

• Antacids may reduce the absorption of iron
• Tetracycline antibiotics may have decreased effectiveness when taken with iron supplements
• Certain food components (e.g., phytates, calcium) may inhibit iron absorption

Precautions

• Use with caution in patients with gastrointestinal disorders
• Monitor for signs of iron overload, particularly in patients with hemochromatosis or hemosiderosis
• Ensure adequate dietary intake of vitamin C to enhance iron absorption

Pregnancy

Iron supplementation is often necessary during pregnancy to prevent and treat iron deficiency anemia, but should be done under medical supervision.

Breast-feeding

Iron is important for lactating women, and supplementation may be necessary to meet increased nutritional needs, but consult a healthcare professional.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Tablets
• Capsules
• Oral solutions
• Injections

Indications

• Eclampsia
• Severe asthma exacerbations
• Torsades de pointes
• Magnesium deficiency
• Cardiac arrhythmias
• Pre-eclampsia

Dosage

Children: Refer to relevant paediatric guidelines for specific dosing recommendations based on the indication and patient condition.

Adults: Refer to relevant clinical guidelines for specific dosing recommendations based on the indication and patient condition.

Mechanism of action

Magnesium sulfate acts as a neuromuscular blocker and a smooth muscle relaxant. It competes with calcium for entry into cells, which inhibits the release of acetylcholine at the neuromuscular junction, leading to muscle relaxation. Additionally, it stabilizes excitable membranes and reduces the release of inflammatory mediators, which is particularly useful in treating conditions like asthma and pre-eclampsia.

Pharmacodynamics

The pharmacodynamics of magnesium sulfate involves its role as a cofactor in numerous enzymatic reactions and its impact on the neuromuscular transmission. It contributes to the stabilization of excitable membranes and modulates calcium levels in the body, which is crucial for muscle contraction and neurotransmission. This results in decreased neuromuscular excitability, leading to muscle relaxation and reduced spasms.

Pharmacokinetics

Magnesium sulfate is absorbed following parenteral administration, with peak concentrations occurring within minutes. The distribution half-life is approximately 1-2 hours, and it is primarily eliminated through the kidneys. In cases of renal impairment, magnesium sulfate can accumulate, necessitating careful monitoring of renal function and magnesium levels.

Pregnancy

Consult healthcare provider before use, as safety during pregnancy has not been established.

Breast-feeding

Consult healthcare provider before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place, away from moisture and direct sunlight.